Prolonged SARS-CoV-2 infection during autologous hematopoietic stem cell transplantation from Hodgkin's lymphoma: a case report.
Pan Afr Med J
; 44: 133, 2023.
Artículo
en Inglés
| MEDLINE | ID: covidwho-2290450
ABSTRACT
Autologous hematopoietic stem cell transplantation (HSCT) for relapsed Hodgkin's lymphoma increases the risk of infection by using intensive chemotherapy. This risk is obviously ongoing given the increased virulence of severe COVID-19. We report a case of a young man with Hodgkin's lymphoma who received conditioning chemotherapy followed by autologous HSCT and tested positive for SARS-CoV-2 by polymerase chain reaction (PCR) during the early phase of aplasia with persistence of COVID-19 beyond 30 days with favorable follow-up and clinical improvement on treatment. For this type of patient with hematologic malignancy, viral infection can be fatal and strict medical precautions with isolation rules must be maintained, especially for SARS-CoV-2.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Enfermedad de Hodgkin
/
Trasplante de Células Madre Hematopoyéticas
/
COVID-19
Tipo de estudio:
Reporte de caso
/
Estudio de cohorte
/
Estudio pronóstico
Límite:
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Pan Afr Med J
Año:
2023
Tipo del documento:
Artículo
País de afiliación:
Pamj.2023.44.133.36277
Similares
MEDLINE
...
LILACS
LIS